F-18 FDG-PET as a routine surveillance tool for the detection of recurrent head and neck squamous cell carcinoma.
暂无分享,去创建一个
Jeong Hyun Lee | Jae Seung Kim | Sang‐wook Lee | Sung-Bae Kim | S. Choi | S. Nam | Jong Cheol Lee | S. Kim
[1] Jin-Sook Ryu,et al. Early evaluation of the response to radiotherapy of patients with squamous cell carcinoma of the head and neck using 18FDG-PET. , 2005, Oral oncology.
[2] Q. Le,et al. Positron‐Emission Tomography for Surveillance of Head and Neck Cancer , 2005, The Laryngoscope.
[3] A. Hogg,et al. Usefulness of fluorine‐18 fluorodeoxyglucose positron emission tomography in patients with a residual structural abnormality after definitive treatment for squamous cell carcinoma of the head and neck , 2004, Head & neck.
[4] T. Yen,et al. Clinical usefulness of 18F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[5] H. Foehrenbach,et al. Fdg-Pet Scan in Local Follow-up of Irradiated Head and Neck Squamous Cell Carcinomas , 2004, The Annals of otology, rhinology, and laryngology.
[6] C. R. Leemans,et al. Genetically Altered Fields as Origin of Locally Recurrent Head and Neck Cancer , 2004, Clinical Cancer Research.
[7] Mithat Gonen,et al. Diagnostic and Prognostic Value of [18F]Fluorodeoxyglucose Positron Emission Tomography for Recurrent Head and Neck Squamous Cell Carcinoma , 2002 .
[8] R. D'Agostino,et al. Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer , 2001, Head & neck.
[9] P. V. van Rijk,et al. F‐18‐fluoro‐deoxy‐glucose positron‐emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/ pharyngeal cancer , 2001, Head & neck.
[10] M. Remacle,et al. Positron Emission Tomography With Fluorodeoxyglucose for Suspected Head and Neck Tumor Recurrence in the Symptomatic Patient , 2000, The Laryngoscope.
[11] B C Stack,et al. Surveillance for recurrent head and neck cancer using positron emission tomography. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] A. Alavi,et al. Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2‐18f‐fluoro‐2‐deoxy‐D‐glucose positron emission tomography , 1999, The Laryngoscope.
[13] K. Geisinger,et al. Pet scanning in head and neck oncology: A review , 1998, Head & neck.
[14] J. Bourhis,et al. Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 GY in 7 weeks. , 1996, International journal of radiation oncology, biology, physics.
[15] H. Minn,et al. Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18 fluorodeoxyglucose. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[16] G. V. von Schulthess,et al. Positron emission tomography in the early follow-up of advanced head and neck cancer. , 2004, Archives of otolaryngology--head & neck surgery.
[17] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.
[18] C. Balch,et al. AJCC Cancer Staging Manual. 6th ed , 2002 .
[19] S. Manolidis,et al. The use of positron emission tomography scanning in occult and recurrent head and neck cancer. , 1998, Acta oto-laryngologica. Supplementum.